| Predictors | Absolute change in Physician Global VAS 24 weeks after treatment (n = 177) | Absolute change in Muscle Disease Activity VAS 24 weeks after treatment (n = 177) | Absolute change in Extra-muscular Global VAS 24 weeks after treatment (n = 177) |
|
| Coefficient | Coefficient | Coefficient |
| Intercept | −11.64 | −15.07 | −6.76 |
| Race (Caucasian) | - | - | - |
| Physician Global VAS | −0.12 | - | - |
| Muscle Disease Activity VAS | - | −0.09 | - |
| Extramuscular Global VAS | - | - | −0.13 |
| Pulmonary Disease Activity VAS | - | - | - |
| Presence of anti-Mi-2 | - | - | - |
| IFN chemokine score | −0.06 | - | - |
| IL-2, pg/mL | - | - | - |
| MIP-1β, pg/mL | - | - | - |
| Cross-validated R2 | 0.13 | 0.05 | 0.14 |